Abstract
Nanosized lipid carriers (NLC) can improve the limited drug-loading (DL) capacity and drug expulsion during storage, and adjust the drug release profile of solid lipid nanoparticles (SLN). In this study, Paclitaxel (PTX)-loaded NLC were prepared by solvent diffusion method using monostearin as solid lipid and oleic acid (OA) as liquid lipid matrix. The blank NLC with different OA content (the size range was from 89.5 ± 7.4 to 160.2 ± 34.6 nm) showed smaller size than the blank SLN (the size was 272.7 ± 43.6 nm), while the PTX-loaded NLC (the size range was from 481.3 ± 29.8 to 561.7 ± 38.3 nm) showed little bigger size, higher DL capacity, and faster drug in vitro release rate comparing with SLN (the size was 437.3 ± 68.2 nm). The 50 % cellular growth inhibitions (IC50) of PTX-loaded NLC with 0, 5, 10, and 20 wt % OA were 0.92 ± 0.06, 0.69 ± 0.04, 0.25 ± 0.02, and 0.12 ± 0.02 µg mL−1, respectively, while the IC50 of TaxolTM was 1.72 ± 0.09 µg mL−1. For analyzing cellular drug effect, cellular uptakes of fluorescent NLC and intracellular drug concentration were investigated. As the incorporation of OA into solid lipid matrix could accelerate both the cellular uptake and the PTX delivery, loaded by NLC, the cytotoxicity of PTX could be enhanced, and further enhanced by increasing OA content in NLC.
Similar content being viewed by others
References
Benis S, Chapey C, Couvreur P, Robert J (1994) Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multi-drug resistant cells in culture. Eur J Cancer 30A:89–93
Brigger I, Dubernet C, Couvreur P (2002) Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 54:631–651
Castelli F, Puglia C, Sarpietro MG, Rizza L, Bonina F (2005) Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Int J Pharm 304:231–238
Chávez JL, Wong JL, Duran RS (2008) Core-Shell Nanoparticles: characterization and study of their use for the encapsulation of hydrophobic fluorescent dyes. Langmuir 24:2064–2071
Ding JC, Hu FQ, Yuan H (2004) Uptake of monostearin solid lipid nanoparticles by A549 cells. Acta Pharm Sin 39:876–880
Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos D (1999) Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 51:691–744
Garrec DL, Ranger M, Leroux JC (2004) Micelles in anticancer drug delivery. Am J Drug Deliv 2:15–42
Gelderblom H, Verweij J, Nooter K, Sparreboom A (2001) Sparreboom. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 37:1590–1598
Gualbert J, Shahgaldian P, Coleman AW (2003) Interactions of amphiphilic calix[4] arene-based solid lipid nanoparticles with bovine serum albumin. Adv Drug Deliv Rev 57:69–73
Heo DN, Yang DH, Moon HJ, Lee JB, Bae MS, Lee SC, Lee WJ, Sun IC, Kwon IK (2012) Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy. Biomaterials 33:856–866
Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S (2005) Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B 45:167–173
Hu FQ, Ren GF, Yuan H, Du YZ, Zeng S (2006) Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel. Colloids Surf B 50:97–103
Hu Y, Zheng XT, Chen JS, Zhou MJ, Li CM, Lou XW (2011) Silica-based complex nanorattles as multifunctional carrier for anticancer drug. J Mater Chem 21:8052–8056
Jenning V, Gohla SH (2001) Encapsulation of retinoids in solid lipid nanoparticles (SLN). J Microencapsul 18:149–158
Jenning V, Andreas FT, Gohla SH (2000a) Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 199:167–177
Jenning V, Mader K, Gohla SH (2000b) Solid lipid nanoparticles (SLNTM) based on binary mixtures of liquid and solid lipids: a 1HNMR study. Int J Pharm 20:15–21
Jores K, Mehnert W, Drechsler M, Bunjes H, Johann C, Mäder K (2004) Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release 95:217–227
Maschke A, Becker C, Eyrich D, Kiermaier J, Blunka T, Göpferich A (2007) Development of a spray congealing process for the preparation of insulin-loaded lipid microparticles and characterization. Eur J Pharm Biopharm 65:175–187
Miao J, Du YZ, Yuan H, Zhang XG, Hu FQ (2013) Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells. Colloids Surf B 110:74–80
Montasser I, Fessi H, Coleman AW (2002) AFM imaging of novel type of polymeric colloidal nanostructures. Eur J Pharm Biopharm 54:281–284
Mu L, Feng SS (2002) Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheresfor controlled release of paclitaxel (Taxol). J Control Release 80:129–144
Mühlen AZ, Mühlen EZ, Niehus H, Mehnert W (1996) Atomic force microscopy studies of solid lipid nanoparticles. Pharma Res 13:1411–1416
Müller RH, Jacobs C, Kayser O (2001) Nanosuspensions as particulate drug formulations in therapy Rationale for development and what we can expect for the future. Adv Drug Deliv Rev 47:3–19
Müller RH, Radtke M, Wissing SA (2002a) Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242:121–128
Müller RH, Radtke M, Wissing SA (2002b) Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54:S131–S155
Serpe L, Catalano MG, Cavalli R, Ugazio E, Bosco O, Canaparo R, Muntoni E, Frairia R, Gasco MR, Eandi M, Zara GP (2004) Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line. Eur J Pharm Biopharm 58:673–680
Shahgaldian P, Silva ED, Anthony W (2003) Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): a detailed study of preparation and stability parameters. Int J Pharm 253:23–28
Souto EB, Wissing SA, Barbosa CM (2004a) Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 278:71–77
Souto EB, Wissing SA, Barbosa CM, Müller RH (2004b) Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Eur J Pharm Biopharm 58:83–90
Tranchant T, Besson P, Hoinard C, Delarue J, Antoine JM, Couet C, Goré J (1997) Mechanisms and kinetics of α-linolenic acid uptake in Caco-2 clone TC7. Biochim Biophys Acta 1345:151–161
Yang XY, Li YX, Li M, Zhang L, Feng LX, Zhang N (2013) Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer. Cancer Lett 334:338–345
Yuan H, Miao J, Du YZ, You J, Hu FQ, Zeng S (2008) Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int J Pharm 348:137–145
Zhan CY, Gu B, Xie C, Li J, Liu Y, Lu WY (2010) Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel antiglioblastoma effect. J Control Release 143:136–142
Zhang XG, Miao J, Dai YQ, Du YZ, Yuan H, Hu FQ (2008) Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells. Int J Pharm 361:239–244
Acknowledgments
We appreciate the financial support from the National Nature Science Foundation of China (No. 81200428, No. 81402862 and No. 81400958), General research project of Zhejiang province health department (2013KYA073), and the National Construction Project of Key Clinical Specialties(Clinical pharmacy).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Miao, J., Du, Y., Yuan, H. et al. Improved cytotoxicity of paclitaxel loaded in nanosized lipid carriers by intracellular delivery. J Nanopart Res 17, 10 (2015). https://doi.org/10.1007/s11051-014-2852-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-014-2852-x